CSPC PHARMA (01093.HK) -0.030 (-0.435%) Short selling $134.03M; Ratio 30.909% has announced its annual results for the year ended December 2024. The company's turnover declined by 7.8% YoY to RMB29.009 billion, while its net profit amounted to RMB4.328 billion, down 26.3% YoY, with EPS standing at RMB36.87 cents. Its GPM also edged down by 0.5 ppts to 70.0%.